Registered entities
Senti Biosciences, Inc.
Reg. No. 1854270United States
Innovation
56 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 1,854 times.
| Year | Filings |
|---|---|
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 12 |
| 2022 | 23 |
| 2023 | 24 |
| 2024 | 33 |
| 2025 | 31 |
| 2026 | 8 |
Social engagement
Social engagement: 12K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
32 investors on record; lead investors include Leaps by Bayer, New Enterprise Associates, Celadon Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 19 | 59% |
| Private equity | 4 | 13% |
| Bank & private debt | 2 | 6% |
| Other / undisclosed | 7 | 22% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
7 Feb 2026 · Accounts Payable Contractor · South San Francisco
Based on job postings tracked across public sources.
Recent activity
14 May 2026
Milestone
regulatory
14 May 2026
Milestone
regulatory